天眼查App显示，近日，麦苏迪（新沂）生物工程有限公司成立，法定代表人为邵金超，注册资本166 万人民币，经营范围为一般项目：生物有机肥料研发；复合微生物肥料研发；水污染治理；水环境污染 防治服务；土壤环境污染防治服务；日用化学产品制造；日用化学产品销售；饲料添加剂销售；饲料原 料销售；专用化学产品销售（不含危险化学品）；互联网销售（除销售需要许可的商品）；消毒剂销售 （不含危险化学品）；工业酶制剂研发；生态环境材料销售；宠物食品及用品批发；宠物食品及用品零 售；环境保护专用设备销售；货物进出口；畜牧渔业饲料销售；水生植物种植；宠物服务（不含动物诊 疗）；企业管理咨询；机械设备销售；日用杂品销售；日用品销售；化妆品批发；化妆品零售；大气环 境污染防治服务；卫生用杀虫剂销售；技术服务、技术开发、技术咨询、技术交流、技术转让、技术推 广（除依法须经批准的项目外，凭营业执照依法自主开展经营活动）。 ...

该系统采用先进的管板同轨磁驱轨道传输技术和信息化组网方式，涵盖样本自动处理、酶免加样、酶免检测、血型分析及样本回收存储 等多个功能模块，实现从样本录入到结果输出全程自动化。可同时开展艾滋、梅毒、乙肝、丙肝、血型等多个检测项目，多任务并行、 大通量处理，实现了检测过程可追溯、低干预。 烟台市中心血站检验实验室全自动检测流水线正式投入使用，有效提升了血液检测的智慧化、信息化与标准化水平，能够提高检测准确 性，进一步保障血液质量安全，同时大大提高工作效率，降低实验室生物安全风险。下一步，烟台市中心血站将继续优化检测体系，深 化技术创新，强化血液质量管理，为临床安全用血提供坚实保障。 2025年7月，烟台市中心血站与烟台澳斯邦生物工程有限公司携手启动"血站检验实验室全自动检测流水线"孵化项目。该项目重点对血站 检验科原有单体检测设备进行整合，通过澳斯邦公司最新研发的磁驱轨道技术，构建完整高效的检测流水线系统。 在前期设计阶段，双方充分考虑实验室原有设施条件、设备兼容性、检测流程的契合与自动化，在保证与现有检测模式高度匹配的前提 下，推动检测系统有机融入日常工作。血站检验科人员与厂家工程师通力协作，在两个月时间里，顺利 ...

近年来，陕西高度重视民营经济高质量发展，接续出台《关于促进民营经济加快发展的若干意见》 《民营经济高质量发展三年行动计划（2021—2023年）》《大力服务民营经济高质量发展十条措施》， 成立"省促进民营经济发展工作领导小组"，统筹推进民营经济持续健康发展。2024年，全省民营经济增 加值17581亿元，占全省GDP的49.5%。今年上半年，民营经济占全省GDP比重较上年同期上升0.3个百 分点，达到49.8%，支柱作用进一步凸显。 9月16日，全省民营经济高质量发展"七大行动"学习宣传会在西安召开，省工信厅、省发展改革 委、省司法厅、省市场监督管理局对《陕西省进一步促进民营经济高质量发展"七大行动"实施方案》进 行全面解读，鼓励引导广大民营企业和民营企业家坚定信心、主动作为、大胆创新，为全省经济社会高 质量发展作出新的更大贡献。 今年，省委、省政府深入贯彻落实习近平总书记在民营企业座谈会上的重要讲话精神，开展进一步 促进民营经济高质量发展"七大行动"。省工信厅会同省级相关部门，广泛征求吸收民营企业意见建议， 从政策可感可及、破除市场准入壁垒、金融惠企纾困、加大要素支持、规范涉企检查、"高效办成一件 事"、强 ...

Core Viewpoint - The announcement details the conditional redemption of "Kehua Convertible Bonds" by Shanghai Kehua Bioengineering Co., Ltd., triggered by specific stock price conditions and outlines the redemption process and terms [1][2][3]. Redemption Conditions - The redemption price is set at 100.241 RMB per bond (including interest and tax) [1][6]. - The triggering date for the redemption conditions is September 5, 2025, when the stock price falls below 70% of the conversion price for 30 consecutive trading days [1][2]. - The redemption is not mandatory, allowing bondholders to choose whether to redeem their bonds [1][7]. Redemption Process - The redemption application period is from September 10 to September 16, 2025 [2][9]. - The funds will be credited to the issuer on September 19, 2025, with the redemption payment date set for September 22, 2025, and investors will receive their funds by September 23, 2025 [2][9]. Interest Calculation - The interest for the redemption is calculated using the formula: IA = B × i × t / 365, where the interest rate (i) is 2.00% for the sixth interest year [4][5]. - The calculated interest per bond is 0.241 RMB, leading to a total redemption price of 100.241 RMB per bond [5][6]. Trading and Conversion Restrictions - During the redemption application period, "Kehua Convertible Bonds" will continue to trade but will not allow conversion into shares [9]. - If bondholders submit multiple requests (trading, conversion, redemption) on the same day, they will be processed in a specific order: trading, redemption, conversion, and transfer [9].

"无锡高新区—江南大学"位列其中。双方成功组成"CP"，产业与学科的高度契合是重要原因——江 南大学在食品科学与工程、生物工程等领域拥有深厚实力，可直接赋能无锡高新区特殊食品、合成生物 制造等主导产业。目前，双方合作及在谈重大项目达15项，涉及合作资金超13亿元。 9月1日，无锡高新区与江南大学"双高协同"第一次联席会议召开。会上，江南大学、先导智能、食 检中心、罗益生物、布勒机械签约"双高协同"首批重大项目，一批"产业教授""科技副总"受聘上岗，双 方共建的"双高协同"成果转化基金揭牌。 高新区和高校，都是科创资源富集的创新主阵地。江苏拥有61家省级以上高新区，其中18家为国家 级高新区，数量居全国第一；同时拥有175所高等院校，数量和质量均位居全国前列。如何变资源优势 为发展优势，江苏给出了自己的答案——以"有组织科研+有组织转化"为实施路径，推动高新区和高 校"双高协同"创新发展。 今年5月，江苏省科技厅、省教育厅联合发布"双高协同"试点申报通知，按下了"双高协同"启动 键。7月，首批试点单位敲定，全省18家高新区和37所高等院校组成"创新CP"。 "双高协同"的探索正在江苏全省铺开。7月22日，南京鼓 ...

Group 1 - The Taicang Beer Carnival, which started in 2006, has become a significant cultural and economic bridge between China and Germany, celebrating its 20th anniversary this year [1][2] - The event reflects the deep-rooted cooperation between Taicang and German enterprises, with over 560 German companies now established in the region, marking Taicang as a hub for German businesses in China [1][3] - The carnival symbolizes the cultural integration and emotional resonance between the two nations, evolving from a simple gathering to a major city event that showcases Taicang's development as a "German enterprise hometown" [2][3] Group 2 - Taicang has developed a comprehensive "German enterprise ecosystem" over the past 30 years, expanding cooperation beyond economic sectors to include culture, education, and sports [3][6] - The city has hosted various cultural events and exchanges, such as the "Taicang Day" in Germany, which highlights the depth of cooperation in trade, education, and culture [4][6] - The establishment of dual vocational training centers in Taicang has supported the local German enterprises by providing a skilled workforce, with over 10,000 trained professionals [7] Group 3 - Taicang's strategic location near Shanghai and its robust transportation network have made it an attractive destination for German companies, with a significant number of them being industry leaders [5][6] - The city has initiated the planning of a Sino-German industrial cooperation demonstration zone to enhance economic collaboration and facilitate the entry of German enterprises [8] - Recent projects, including the establishment of a brand factory by Henkel and expansions by other leading companies, indicate a growing confidence among German firms in Taicang [9][10]

Group 1 - The core viewpoint emphasizes the need for developing new quality productivity in the new economic era, integrating technological, digital, and industrial advancements to foster contemporary advanced productivity [1] - Yichang has 457 state-owned and state-controlled enterprises, focusing on modern chemical new materials, life health, new energy, high-end equipment, big data, cultural tourism, and real estate [1][2] - The 2025 Yichang Government Work Report calls for the vigorous development of new quality productivity and the promotion of safe and healthy development of emerging industries, including biomanufacturing, quantum technology, embodied intelligence, and 6G [1][2] Group 2 - Yichang's state-owned enterprises are primarily involved in fine chemical industries and must focus on transforming towards new technologies, industries, and business models while enhancing product quality and efficiency through digitalization and green practices [2][3] - The strategy includes optimizing state capital in strategic emerging industries such as biomedicine, new materials, and renewable energy, aiming to seize future development opportunities [2][3] Group 3 - The promotion of technological innovation is crucial for leading the forefront of the era, focusing on original and disruptive innovations to achieve high-level technological self-reliance [3] - Emphasis is placed on transforming technological achievements into productive forces and enhancing traditional industries while nurturing emerging industries [3][4] Group 4 - The integration of industries is highlighted as a new trend in global economic development, driven by digitalization and intelligent technologies, which is essential for cultivating and expanding advantageous industries [4] - The strategy includes promoting the fusion of the internet with manufacturing, cultural and tourism industries, and leveraging big data and AI for collaborative innovation [4] Group 5 - The importance of human resources as the primary resource for new quality productivity is stressed, with a focus on enhancing talent cultivation and attracting high-end professionals [5] - The establishment of a robust mechanism for talent training, introduction, and mobility is essential for fostering a skilled workforce to support high-quality development [5]

Core Viewpoint - The article discusses the evolution of skeletal muscle tissue engineering from medical needs to a key technology driving the development of biorobotics, highlighting its potential in both medical applications and robotics [1][2]. Group 1: Medical Needs and Challenges - Skeletal muscle constitutes over 40% of body weight and is essential for movement. Loss of more than 15%-20% of muscle can lead to permanent functional loss [4]. - Current treatment options primarily rely on autologous muscle transplantation, which has limitations such as donor site availability, significant surgical trauma, and suboptimal functional recovery [4]. Group 2: Development of Skeletal Muscle Tissue Engineering - Clinical needs have propelled the development of skeletal muscle tissue engineering, aiming to cultivate functional muscle tissue in vitro for repairing large muscle defects [5]. - Researchers discovered broader applications in biorobotics, as engineered muscle offers unique advantages such as high mechanical compliance, energy efficiency, and fine motor control [5]. Group 3: Key Strategies in Muscle Tissue Engineering - The core strategies in skeletal muscle tissue engineering include scaffold design, cell sourcing, external stimulation, and bioreactor technology, all of which are continuously innovating [5]. Group 4: Scaffold and Cell Selection - Scaffolds provide three-dimensional support for cell growth and must meet strict requirements such as biocompatibility, degradation rate matching tissue regeneration, and hardness close to natural muscle (10-20 kPa) [6]. - Various materials are explored, including synthetic polymers like PCL and PLGA, and natural materials like fibrin and collagen. Innovative approaches include using decellularized plant tissues as scaffolds [6]. - In cell selection, satellite cells are the best for differentiation but are difficult to obtain, while mesenchymal stem cells are easier to acquire but have limited differentiation potential [7]. Group 5: Stimulation and Cultivation Techniques - To make engineered muscle functional, it is essential to simulate physiological environments and provide appropriate stimulation signals, including mechanical, electrical, and biochemical stimuli [8]. - Mechanical stimulation is crucial, with optimal substrate hardness (8-11 kPa) and dynamic stretching (35% strain rate) promoting muscle fiber alignment and maturation [8]. - Electrical stimulation mimics motor neuron activation, significantly increasing muscle contraction force by three times through intermittent stimulation [8]. Group 6: Biorobotics and Muscle-Driven Robots - The integration of skeletal muscle tissue engineering with robotics has led to the emergence of biohybrid robots, which utilize engineered muscle tissue as actuators, offering advantages over traditional motors [12]. - These muscle actuators allow for fine control, inherent compliance, and the potential for self-repair and adaptive growth [12]. - Various proof-of-concept muscle-driven robots have been developed, including a notable 18 cm tall biohybrid hand capable of selective finger movement [13]. Group 7: Future Prospects - The future of skeletal muscle tissue engineering is promising, with potential applications in personalized tissue transplantation for muscle loss patients, new soft actuator systems in robotics, and other fields like cultured meat production and drug screening [14]. - This interdisciplinary field combines insights from biology, engineering, and materials science, generating valuable new knowledge and innovations [14].

Group 1 - The core viewpoint of the article is that Capital界金控 (00204) has signed a strategic cooperation letter of intent with Henan Life Tree Biotechnology Co., Ltd. (Life Tree) [1] - Life Tree is a biotechnology company focused on autonomous innovation, integrating cell research, clinical transformation, and industrial equipment to create a cutting-edge technology matrix [1] - The strategic cooperation is aligned with the long-term development goals and business strategies of the company, potentially providing profit growth opportunities for both parties [1]

Core Viewpoint - The announcement indicates that Capital World Financial Holdings (00204) has signed a strategic cooperation letter of intent with Henan Life Tree Biotechnology Co., Ltd, aiming to enhance long-term development goals and business strategies [1] Group 1: Company Overview - Life Tree is a biotechnology company driven by independent innovation, integrating cell research, clinical transformation, and industrial equipment [1] - The company focuses on self-developed automated equipment and medical devices, breaking technical barriers and leading the new standard for large-scale and standardized cell preparation [1] Group 2: Strategic Cooperation - The strategic cooperation is expected to create potential profit growth points for both parties, aligning with the overall interests of the company and its shareholders [1] - The collaboration aims to address diverse needs through customized cell application solutions, emphasizing the commitment to advancing biotechnological innovation [1]